Patient | Age (years) | Sex (M/F) | Disease duration (months) | DMARDs1-150 | CRP1-150(mg/l) | RF1-150(+/−) | Erosions (+/−) |
1 | 54 | M | 30 | Plaquenil | 14 | − | + |
2 | 55 | M | 276 | — | 37 | − | − |
3 | 48 | F | 84 | MTX1-150 | 4 | − | + |
4 | 65 | M | 288 | MTX | 27 | + | + |
5 | 58 | F | 276 | MTX | 17 | − | + |
6 | 80 | F | 336 | Prednisone | 45 | + | + |
7 | 80 | F | 336 | Prednisone | 45 | + | + |
8 | 43 | F | 120 | MTX, prednisone, cyclosporin | 29 | + | + |
9 | 77 | M | 17 | Gold | 1 | − | − |
10 | 76 | F | 120 | Cyclosporin | 46 | + | + |
11 | 72 | F | 13 | — | 35 | + | + |
12 | 60 | F | 24 | Plaquenil | 80 | − | − |
13 | 77 | M | 180 | Gold | 16 | + | + |
14 | 70 | M | 1 | Gold, MTX | 116 | + | − |
15 | 75 | F | 3 | Gold | 47 | + | − |
16 | 76 | F | 1 | Gold | 32 | − | − |
17 | 59 | F | 216 | MTX | 108 | + | + |
↵1-150 DMARDs = disease modifying antirheumatic drugs; CRP = C reactive protein; RF = rheumatoid factor, MTX = methotrexate.